Hodgkin lymphoma trials in Czechia

In Czechia 7 Also abroad 156

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Prague
Age
Up to 17 years
People
37 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00
No phaseTaking people
Early Detection and Screening of Hematological Malignancies - SANGUINE
Where
Olomouc
Age
18 years and over
People
3,000 worldwide
Run by
JaxBio Ltd
See details and how to joinNCT05735704
Phase 3Taking people
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Where
Ostrava, Plzen 23, Praha 10
Age
18 years and over
People
49 worldwide
Run by
Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00
Phase 1Taking people
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Where
Ostrava, Prague, Prague 10
Age
18 years and over
People
121 worldwide
Run by
ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00
Phase 3Taking people
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
Where
Prague 10
Age
18 years and over
People
132 worldwide
Run by
Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00
Phase 1Taking people
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
Where
Prague
Age
18 years to 80 years
People
10
Run by
Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257 · EU 2024-510815-30-00
No phaseTaking people
Prognostic Significance of ctDNA in HL
Where
Hradec Králové, Olomouc, Prague
Age
18 years and over
People
500
Run by
Interni hematologicka klinika FNKV
See details and how to joinNCT06263530